Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
One A Day is a leading global brand of multivitamin supplements, currently operating as a core part of Bayer's Consumer Health division. Originally launched in 1940 by Miles Laboratories, the brand pioneered the concept of a single daily tablet to meet essential nutritional requirements. Today, the portfolio includes a wide range of specialized formulations designed for specific demographics, including gender-specific multivitamins, prenatal supplements, and age-targeted products for seniors. The brand focuses on addressing common micronutrient gaps and supporting various health areas such as bone density, heart health, and immune function. One A Day products are widely distributed through major retail and pharmaceutical channels, maintaining a significant presence in the over-the-counter wellness market. The brand continues to innovate with new delivery formats, such as gummies and fruit bites, to meet evolving consumer preferences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on One A Day.